Mode
Text Size
Log in / Sign up

Early surgery reduces cardiovascular death risk in asymptomatic very severe aortic stenosis over 10 yearsShould doctors operate before symptoms appear for a severe heart valve problem?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider early surgery for asymptomatic very severe aortic stenosis based on 10-year mortality reduction, but safety data are lacking.

A randomized controlled trial followed 145 asymptomatic patients with very severe aortic stenosis (aortic-valve area ≤0.75 cm² with peak aortic jet velocity ≥4.5 m/s) for 10 years. Patients were assigned to either early surgery or conservative care, with the primary outcome being a composite of operative mortality or death from cardiovascular causes during follow-up.

Early surgery resulted in significantly lower rates of the primary composite outcome, occurring in 2 of 73 patients (3%) compared to 17 of 72 patients (24%) in the conservative-care group (hazard ratio 0.10; 95% CI, 0.02 to 0.43; P=0.002). The cumulative incidence at 10 years was 1% versus 19%. All-cause mortality was also lower with early surgery (15% vs. 32%; HR 0.42; 95% CI, 0.21 to 0.86).

Safety and tolerability data were not reported. The study was funded by the Korean Institute of Medicine. Limitations were not explicitly detailed in the provided information, though the absence of safety reporting and specific surgical details should be noted.

For practice, these results from an intention-to-treat RCT analysis suggest early surgery may provide substantial long-term mortality reduction in this specific, high-risk asymptomatic population. However, clinicians should interpret these findings cautiously given the lack of reported safety outcomes and the need to consider individual patient factors and surgical risk.

Imagine having a heart valve so severely narrowed that it's a ticking time bomb, yet you feel perfectly fine. That's the reality of asymptomatic very severe aortic stenosis. Doctors have long debated whether to operate immediately or wait until symptoms like chest pain or shortness of breath appear. A new 10-year study provides a compelling answer.

The research followed 145 patients with this silent but dangerous condition. Half were assigned to get heart valve replacement surgery right away, while the other half received standard conservative care. The results were striking. Over the next decade, only 3% of the early surgery group died from surgery-related complications or other heart causes, compared to 24% of those who waited. Looking at death from any cause, 15% of the surgery group died versus 32% in the conservative care group.

This is powerful evidence that acting early can save lives for this specific group of patients. The study was a randomized trial, which is the gold standard for proving cause and effect. However, the report doesn't detail what kind of surgery patients received, how they tolerated it, or what complications occurred. We also don't know if these results apply to all patients with this condition or just those who met the study's strict criteria. The findings come from a single study funded by a Korean institute, so more research will help confirm them.

What this means for you:
Early surgery may save lives for people with a severe, silent heart valve problem.

Study Details

Study typeRct
Sample sizen = 145
EvidenceLevel 2
Follow-up120.0 mo
PublishedMar 2026
View Original Abstract ↓
BACKGROUND: Among asymptomatic patients with severe aortic stenosis, a previous analysis showed that the risk of a composite of death during surgery or within 30 days after surgery (called operative mortality) or death from cardiovascular causes was significantly lower with early surgery than with conservative care. However, the long-term survival benefit of early surgery, as compared with conservative care, remains unclear. METHODS: We randomly assigned asymptomatic patients with very severe aortic stenosis (defined as an aortic-valve area of ≤0.75 cm with a peak aortic jet velocity of ≥4.5 m per second) in a 1:1 ratio to undergo early surgery or receive conservative care. The primary end point was a composite of operative mortality or death from cardiovascular causes during the 10-year follow-up period. RESULTS: A total of 145 patients underwent randomization. In an intention-to-treat analysis, a primary end-point event occurred in 2 of 73 patients (3%) in the early-surgery group and in 17 of 72 (24%) in the conservative-care group (hazard ratio, 0.10; 95% confidence interval [CI], 0.02 to 0.43; P = 0.002). At 10 years, the cumulative incidence of operative mortality or death from cardiovascular causes was 1% in the early-surgery group and 19% in the conservative-care group. Death from any cause occurred in 11 patients (15%) in the early-surgery group and in 23 (32%) in the conservative-care group (hazard ratio, 0.42; 95% CI, 0.21 to 0.86). CONCLUSIONS: Among asymptomatic patients with very severe aortic stenosis, early surgery led to a lower risk of a composite of operative mortality or death from cardiovascular causes than conservative care at 10 years. (Funded by the Korean Institute of Medicine; RECOVERY ClinicalTrials.gov number, NCT01161732.).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.